Department of Orthopedic, Rizhao Hospital of Traditional Chinese Medicine, Rizhao, Shandong, China.
Eur Rev Med Pharmacol Sci. 2018 May;22(9):2598-2605. doi: 10.26355/eurrev_201805_14953.
Osteosarcoma is the most frequent primary bone malignancy that affects young adults and adolescents around the world. Increasing evidence suggests that dysfunctions of microRNAs (miRNAs) used to play an important role in human cancers. We aimed at evaluating the potential function of miR-16 and verify its influence on the function of RAB23 in osteosarcoma.
miR-16 expressions in osteosarcoma tissues and cell lines were examined using quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR). Transwell chambers were conducted to detect the miR-16 effects on osteosarcoma cells migration and invasion. Meanwhile, Western blot and luciferase assays were performed to validate RAB23 as miR-16 targets.
miR-16 was down-regulated in osteosarcoma cell lines (MG63, SAOS-2, U2OS, and SOSP-9607) and osteosarcoma specimens, while RAB23 expression was higher in tumor tissues. Ectopic over-expression of miR-216 in osteosarcoma cells could inhibit cells migration and invasion. RAB23 was confirmed as a direct target of miR-16 and the inverse relationship between them was also observed. Over-expression of RAB23 ablates the inhibitory effects of miR-16.
miR-16 inhibited cancer migration and invasion, and promoted the RAB23 expression in osteosarcoma. This newly identified miR-16/RAB23 axis may provide new insight into the pathogenesis and represents a potential therapeutic target for osteosarcoma.
骨肉瘤是最常见的原发性骨恶性肿瘤,影响着全球的年轻成年人和青少年。越来越多的证据表明,microRNAs(miRNAs)的功能障碍在人类癌症中起着重要作用。我们旨在评估 miR-16 的潜在功能,并验证其对骨肉瘤中 RAB23 功能的影响。
采用定量逆转录聚合酶链反应(qRT-PCR)检测骨肉瘤组织和细胞系中的 miR-16 表达。通过 Transwell 室检测 miR-16 对骨肉瘤细胞迁移和侵袭的影响。同时,进行 Western blot 和荧光素酶测定以验证 RAB23 是 miR-16 的靶标。
miR-16 在骨肉瘤细胞系(MG63、SAOS-2、U2OS 和 SOSP-9607)和骨肉瘤标本中下调,而 RAB23 在肿瘤组织中的表达较高。在骨肉瘤细胞中过表达 miR-16 可抑制细胞迁移和侵袭。RAB23 被确认为 miR-16 的直接靶标,并且它们之间存在相反的关系。过表达 RAB23 可消除 miR-16 的抑制作用。
miR-16 抑制骨肉瘤的迁移和侵袭,并促进 RAB23 的表达。这个新发现的 miR-16/RAB23 轴可能为发病机制提供新的见解,并代表骨肉瘤的潜在治疗靶点。